Sign up for the QMED & MD+DI Daily newsletter.
March 15, 2016
1 Min Read
Louisville, KY-based Breath Diagnostics has patented its OneBreath technology for early lung cancer detection using the patient’s breath. As CEO Rick Rummel explained in an e-mail, after a patient breathes into a bag, cancer signature compounds are concentrated onto a microchip before being washed off and measured using mass spectrometry.
This allows analysis accuracy on a parts-per-billion level, and OneBreath has been used with more than 700 patients, according to the company’s website.
Breath Diagnostics was one of eight finalists in the Health and Wearable Technologies category of the SXSW Accelerator competition.
[Image courtesy of BREATH DIAGNOSTICS]
Get inspired to innovate during Massachusetts Medtech Week—register for BIOMEDevice Boston 2016, April 13-14.
You May Also Like
Sustainable Manufacturing Expo Hits North AmericaFeb 22, 2024|4 Min Read
Medtronic Doubles Down on Sustainability EffortsFeb 22, 2024|1 Min Read
Top Medical Device M&AFeb 21, 2024|1 Min Read
FDA Urges Independent Verification of Third-Party Testing DataFeb 21, 2024|2 Min Read